MetaCap

Alterity Therapeutics (ATHE) vs Connect Biopharma (CNTB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Alterity Therapeutics (ATHE) has outperformed Connect Biopharma (CNTB) over the past year, losing 22.4% versus a loss of 46.9%. Over five years, ATHE leads with a -74.7% price change compared with -94.5% for CNTB. Alterity Therapeutics is the larger company by market cap ($60.5 million vs $59.5 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ATHE-22.43%CNTB-46.93%
+115%+29%-57%
Oct 7, 20251 yearOct 7, 2026
ATHE-73.86%CNTB-94.85%
+8%-47%-102%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ATHE versus CNTB key metrics
MetricATHECNTB
Share price$3.32$0.9447
Market cap$60.45M$59.49M
1-day change-1.48%+4.34%
YTD return+7.79%-66.50%
1-year return-22.43%-46.93%
5-year return-74.66%-94.50%
EPS (TTM)$-0.89$-1.19
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$5.89$3.82
52-week low$2.66$0.85
Distance from 52-week high-43.63%-75.27%
Average volume16.28K3.82M
Shares outstanding18.21M62.97M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ATHE has outperformed CNTB by 24.5 percentage points over the past year.

ATHE vs CNTB FAQ

Which is bigger, Alterity Therapeutics or Connect Biopharma?

Alterity Therapeutics (ATHE) is larger, with a market capitalization of $60.45M compared with $59.49M for Connect Biopharma (CNTB).

Which stock has performed better over the past year, ATHE or CNTB?

ATHE returned -22.43% over the past 12 months, compared with -46.93% for CNTB (price return, excluding dividends). Past performance does not predict future results.

Are Alterity Therapeutics and Connect Biopharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons